Resultsbee.com

2571 W La Palma Ave,Anaheim,CA

(171) 482 - 7979

9100 Wilshire Blvd Suite # 840 W,Beverly Hills,CA

In the evolving landscape of cancer treatment, the Precision NextGen Oncology and Research Center emerges as a vanguard institution, redefining the paradigms of oncology care and research. At the core of this pioneering facility is an unwavering dedication to innovation, patient-centric care, and the advancement of cancer treatment through cutting-edge clinical trials and specialized care for a wide range of cancers, including the rare and complex sarcomas. Embracing a Wide Spectrum of Cancer Types: Cancer, with its myriad forms and complexities, presents a formidable challenge to patients and healthcare providers alike. The Precision NextGen Oncology and Research Center addresses this challenge head-on by offering comprehensive treatment options tailored to the unique needs of each patient. From Carcinomas to Sarcomas, and from Leukemia to central nervous system cancers, the center's approach is rooted in the understanding that each cancer type demands a specialized strategy. Leveraging advanced treatment modalities such as surgery, chemotherapy, immunotherapy, and targeted therapy, the center aims to deliver not just treatment, but hope and a path towards recovery. Specialized Care for Complex Advanced Cancers, Sarcoma and Rare Cancers The Precision NextGen Oncology and Research Center places a significant emphasis on the treatment of Complex Advanced cancers, sarcoma and rare cancers, recognizing the critical role of specialized care. Under the direction of Dr. Kamlesh Kumar Sankhala, the center is at the forefront of providing cutting edge cancer treatments, sarcoma care, offering tailored treatment plans that consider the intricacies of over 70 Sarcoma subtypes. Through a multidisciplinary approach that involves collaboration with specialized surgeons, radiologists, and pathologists across multiple institutions, the center ensures that each patient receives the most effective and personalized care possible. Innovating Through Clinical Trials Clinical trials represent the heartbeat of innovation at the Precision NextGen Oncology and Research Center. With a focus on Phase-1 clinical trials and a track record of guiding novel cancer drugs from development to patient care, the center is a beacon for those seeking the latest in cancer treatment. By participating in these trials, patients have access to groundbreaking therapies that offer new hope beyond conventional treatment options. The center's efficiency in trial design and execution, coupled with its expertise in molecularly and genetically targeted therapies, underscores its commitment to pushing the boundaries of cancer care. Expert Oncology Care by Dr. Sankhala At the helm of this innovative endeavor is Dr. Kamlesh Kumar Sankhala, a medical oncologist renowned for his expertise in advanced and complex malignancies, rare cancers such as sarcomas. Dr. Sankhala's approach to cancer treatment goes beyond the conventional, incorporating out-of-the-box strategies and personalized medicine to offer patients the best possible outcomes. His leadership in clinical research and drug development has positioned the Precision NextGen Oncology and Research Center as a leader in the field, attracting patients and pharmaceutical collaborations alike. Conclusion The Precision NextGen Oncology and Research Center stands as a testament to what is achievable when innovation, expertise, and compassion converge in the fight against cancer. With a comprehensive range of services for treating all cancer types, specialized care for complex cancers, sarcoma and rare cancers, and a robust clinical trials program, the center is not just a facility for cancer treatment; it is a beacon of hope for patients, families, and the future of oncology care. As we look towards a future where cancer can be combated with greater precision and efficacy, the Precision NextGen Oncology and Research Center is poised to lead the way, transforming the landscape of cancer treatment one patient at a time.

(142) 477 - 7070

18111 Brookhurst St Lower Level, Suite 0300,Fountain Valley,CA

Welcome to Orange County Cyberknife & Radiation Oncology Center At Orange County Cyberknife & Radiation Oncology Center, our mission is to help our patients successfully battle cancer and lead full, healthy lives. We provide a comprehensive approach to cancer treatment, employing state-of-the-art technology along with the most effective and innovative treatments in the field. We firmly believe that no matter how serious the outlook, there is a way to get through it, and we are committed to working with you to help you achieve a healthy, happy life. Hope, Founded on Proven Treatments If you or your loved one has just been diagnosed with cancer, we know how difficult things are right now. A cancer diagnosis can turn your life upside down and often, your options for treatment can seem more like a confusing web of specialists and procedures than a road to a healthier you. Rest assured though that at Orange County Cyberknife, we are here to help. Our team of cancer specialists have years of experience battling cancer of every type and stage, and we employ the latest technology and most effective, innovative treatments in the field. We know how arduous the battle may look now, but with dedication, support, and the help of our expert specialists, we can beat cancer together. Contact Your Orange County Cancer Specialists Today If you are ready to take the next step on the road towards health and healing, we are ready to help you get there. Feel free to call us at (714) 962-7100, learn more about our treatment philosophy, or reach out to us at our contact page. We look forward to hearing from you, and we are excited to help you in the journey to a healthy, happy life.

(171) 496 - 2710

2121 Santa Monica Blvd Garden Level,Santa Monica,CA

Dennis R. Holmes, M.D., F.A.C.S. is an internationally renowned breast cancer surgeon, researcher and innovator with offices in Beverly Hills, Santa Monica, Los Angeles, and Glendale, California. Sought out by patients across Southern California and across the U.S., he specializes in minimally-invasive breast surgery, including oncoplastic surgery, hidden-scar nipple-sparing mastectomy, intraoperative radiotherapy, cryoablation (cancer tumor freezing), and lymph node-sparing surgery. Dr. Holmes is currently serving as Interim Director of the Margie Petersen Breast Center at St. Johns Health Center, and formerly held the positions of Chief Breast Surgeon and Medical Director of the Los Angeles Center for Womens Health, and Chief Breast Cancer Surgeon, and Breast Cancer Research Committee Co-Chair at the University of Southern California (U.S.C.) Kenneth Norris Comprehensive Cancer Center. Dr. Holmes is a 2003 graduate of the U.S.C. Breast Surgery Fellowship Training Program, one of most innovative and progressive breast surgery training programs in the country. He also possesses an extensive  understanding of the roles of oncology, radiation oncology, plastic surgery, and other critical services in the management of breast cancer. In addition, Dr. Holmes has helped train numerous other breast surgeons across the country as former Breast Surgery Fellowship Program Director at U.S.C., and currently as the Breast Surgery Fellowship Program Director at the John Wayne Cancer Institute at Providence St. Johns Health Center. Dr. Holmes is a leader in several national surgical societies and is a frequent lecturer at national conferences. As a member of the education committee of the American Society of Breast Surgeons, Dr. Holmes recently led the development of national surgical practice guidelines for the use of preoperative chemotherapy prior to breast cancer surgery. He is a Fellow of the American College of Surgeons and was also recently selected as Board Chair and President of the TARGIT Collaborative Group, a national research and education organization. Widely respected by colleagues for his innovative approach to breast cancer care, Dr. Holmes is acclaimed worldwide for his pioneering research in targeted intraoperative radiotherapy. He currently serves as National Co-Chair of the TARGIT U.S. Registry clinical trial, and is also National Principal Investigator of the FROST Trial, a clinical trial evaluating the use of cryoablation (tumor freezing) instead of surgery for the treatment of early stage breast cancer. In addition, he has been a pioneer in the field of minimally-invasive breast surgery, including intraoperative radiotherapy, cryoablation, and lymph node-sparing surgery. He is a strong advocate for individualized cancer therapy in which care is adapted to the severity of the cancer to avoiding unnecessary side effects. Where many breast surgeons see challenges, Dr. Holmes sees opportunities. However, what most distinguishes Dr. Holmes among breast surgeons is his commitment to providing women with treatment options that suit their physical and emotional needs, while also providing the best possible cancer control.

(131) 058 - 2710

1245 Wilshire Blvd Suite 303,Los Angeles,CA

Dennis R. Holmes, M.D., F.A.C.S. is an internationally renowned breast cancer surgeon, researcher and innovator with offices in Beverly Hills, Santa Monica, Los Angeles, and Glendale, California. Sought out by patients across Southern California and across the U.S., he specializes in minimally-invasive breast surgery, including oncoplastic surgery, hidden-scar nipple-sparing mastectomy, intraoperative radiotherapy, cryoablation (cancer tumor freezing), and lymph node-sparing surgery. Dr. Holmes is currently serving as Interim Director of the Margie Petersen Breast Center at St. Johns Health Center, and formerly held the positions of Chief Breast Surgeon and Medical Director of the Los Angeles Center for Womens Health, and Chief Breast Cancer Surgeon, and Breast Cancer Research Committee Co-Chair at the University of Southern California (U.S.C.) Kenneth Norris Comprehensive Cancer Center. Dr. Holmes is a 2003 graduate of the U.S.C. Breast Surgery Fellowship Training Program, one of most innovative and progressive breast surgery training programs in the country. He also possesses an extensive  understanding of the roles of oncology, radiation oncology, plastic surgery, and other critical services in the management of breast cancer. In addition, Dr. Holmes has helped train numerous other breast surgeons across the country as former Breast Surgery Fellowship Program Director at U.S.C., and currently as the Breast Surgery Fellowship Program Director at the John Wayne Cancer Institute at Providence St. Johns Health Center. Dr. Holmes is a leader in several national surgical societies and is a frequent lecturer at national conferences. As a member of the education committee of the American Society of Breast Surgeons, Dr. Holmes recently led the development of national surgical practice guidelines for the use of preoperative chemotherapy prior to breast cancer surgery. He is a Fellow of the American College of Surgeons and was also recently selected as Board Chair and President of the TARGIT Collaborative Group, a national research and education organization. Widely respected by colleagues for his innovative approach to breast cancer care, Dr. Holmes is acclaimed worldwide for his pioneering research in targeted intraoperative radiotherapy. He currently serves as National Co-Chair of the TARGIT U.S. Registry clinical trial, and is also National Principal Investigator of the FROST Trial, a clinical trial evaluating the use of cryoablation (tumor freezing) instead of surgery for the treatment of early stage breast cancer. In addition, he has been a pioneer in the field of minimally-invasive breast surgery, including intraoperative radiotherapy, cryoablation, and lymph node-sparing surgery. He is a strong advocate for individualized cancer therapy in which care is adapted to the severity of the cancer to avoiding unnecessary side effects. Where many breast surgeons see challenges, Dr. Holmes sees opportunities. However, what most distinguishes Dr. Holmes among breast surgeons is his commitment to providing women with treatment options that suit their physical and emotional needs, while also providing the best possible cancer control.

(180) 020 - 3551